Ademen secures £1.6M NIHR grant to trial acoustic gut-monitoring device
What's the deal? Midlands start-up AdemenDealroom has a profile for this one. Try Dealroom → has secured a £1.6 million grant from the National Institute for Health and Care ResearchDealroom has a profile for this one. Try Dealroom → (NIHR) to trial its acoustic gut monitoring device.
Co-founded by Alistair Foster, the company built technology that captures and analyses bowel activity, turning gut sounds into objective health data for clinicians.
The device could improve patient monitoring after surgery and, eventually, help detect abdominal conditions earlier.
Why now? The NIHR-funded studies run until November 2028 and will validate the device in real-world healthcare settings, assessing both patient safety and the reliability of its acoustic insights.
Ademen reached this point after support from the Ignite incubation programme, run by the University of Warwick Science ParkDealroom has a profile for this one. Try Dealroom →.
It originally built its core acoustic methods as a digital stethoscope for the veterinary sector but found that market harder to crack than expected. Mentoring helped the team reposition the technology for human healthcare.
What could go wrong? The technology aims to replace clinicians' reliance on patients describing how they feel.
Symptoms like pain or bloating are interpreted differently across individuals and practitioners — and getting it wrong can mean longer hospital stays or misdiagnosis. The trials must now prove the device is both safe and reliable before it can reach hospitals.
The signal: Backing from the National Institute for Health and Care Research, a government and non-profit funder rather than a commercial investor, gives this early-stage startup non-dilutive runway to validate its SAAS-connected sensors through to 2028 — a vote of confidence that the technology can move from veterinary origins into mainstream clinical care.
Read more: UK Science Park Association
